14 February 2017 - The passage of a legislative bill to enable regulatory reform measures stemming from the review of Medicines and Medical Devices Regulation was last week delayed with its referral for Inquiry.
The Senate has referred the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 to the Senate Community Affairs Legislation Committee for inquiry and report. The submissions due date has not yet been set, but the reporting date is 27 March 2017.
AusBiotech supports the Medicines and Medical Devices Regulation's regulatory reforms and efforts to reduce costs and administrative burden for industry, making the assessment process shorter and simpler, while maintaining the safety and quality of medicines and medical devices.